CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Treasury	Common Stock	Additional Paid-in Capital	(Accumulated Deficit) Retained Earnings	(Accumulated Deficit) Retained Earnings Cumulative Effect, Period of Adoption, Adjustment
Beginning balance, shares (in shares) at Feb. 02, 2019			9,979	38,386
Beginning balance at Feb. 02, 2019	$ 20,523	$ 3,322	$ (112,809)	$ 481	$ 128,714	$ 4,137	$ 3,322
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(11,606)					(11,606)
Issuance of restricted stock, net of forfeitures (in shares)				357
Issuance of restricted stock, net of forfeitures	(8)			$ 3	(11)
Stock-based compensation expense	570				570
Acquisition of common stock held in treasury, at cost (in shares)			324	(324)
Acquisition of common stock held in treasury, at cost	(98)		$ (66)	$ (32)
Ending balance, shares (in shares) at Nov. 02, 2019			10,303	38,419
Ending balance at Nov. 02, 2019	12,703		$ (112,875)	$ 452	129,273	(4,147)
Beginning balance, shares (in shares) at Aug. 03, 2019			10,303	38,336
Beginning balance at Aug. 03, 2019	12,060		$ (112,875)	$ 451	129,118	(4,634)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	487					487
Issuance of restricted stock, net of forfeitures (in shares)				83
Issuance of restricted stock, net of forfeitures	(1)			$ 1	(2)
Stock-based compensation expense	157				157
Ending balance, shares (in shares) at Nov. 02, 2019			10,303	38,419
Ending balance at Nov. 02, 2019	12,703		$ (112,875)	$ 452	129,273	(4,147)
Beginning balance, shares (in shares) at Feb. 01, 2020			10,303	38,377
Beginning balance at Feb. 01, 2020	9,108		$ (112,875)	$ 452	129,413	(7,882)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(43,140)					(43,140)
Issuance of restricted stock, net of forfeitures (in shares)				210
Issuance of restricted stock, net of forfeitures	(9)			$ 2	(11)
Stock-based compensation expense	463				463
Ending balance, shares (in shares) at Oct. 31, 2020			10,303	38,587
Ending balance at Oct. 31, 2020	(33,578)		$ (112,875)	$ 454	129,865	(51,022)
Beginning balance, shares (in shares) at Aug. 01, 2020			10,303	38,597
Beginning balance at Aug. 01, 2020	(22,922)		$ (112,875)	$ 454	129,713	(40,214)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(10,808)					(10,808)
Issuance of restricted stock, net of forfeitures (in shares)				(10)
Issuance of restricted stock, net of forfeitures	(2)			$ 0	(2)
Stock-based compensation expense	154				154
Ending balance, shares (in shares) at Oct. 31, 2020			10,303	38,587
Ending balance at Oct. 31, 2020	$ (33,578)		$ (112,875)	$ 454	$ 129,865	$ (51,022)